1. Home
  2. KFY vs SUPN Comparison

KFY vs SUPN Comparison

Compare KFY & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korn Ferry

KFY

Korn Ferry

HOLD

Current Price

$62.66

Market Cap

3.4B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$54.49

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFY
SUPN
Founded
1969
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.8B
IPO Year
1998
2010

Fundamental Metrics

Financial Performance
Metric
KFY
SUPN
Price
$62.66
$54.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$78.00
$61.60
AVG Volume (30 Days)
482.9K
769.2K
Earning Date
03-11-2026
05-21-2026
Dividend Yield
3.09%
N/A
EPS Growth
42.41
N/A
EPS
2.61
N/A
Revenue
$1,819,519,000.00
$392,755,000.00
Revenue This Year
$5.75
$8.18
Revenue Next Year
$4.02
$22.15
P/E Ratio
$23.90
N/A
Revenue Growth
12.20
N/A
52 Week Low
$58.95
$29.16
52 Week High
$78.50
$59.68

Technical Indicators

Market Signals
Indicator
KFY
SUPN
Relative Strength Index (RSI) 46.01 60.20
Support Level $62.46 $47.95
Resistance Level $63.51 $57.65
Average True Range (ATR) 2.11 2.21
MACD 0.13 0.38
Stochastic Oscillator 39.64 48.73

Price Performance

Historical Comparison
KFY
SUPN

About KFY Korn Ferry

Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: